The inability to pay for health care has reached its highest point in the United States, according to the results of a survey released April 2 by the West Healt ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Weeks after ordering staff back to the office, the US Food and Drug Administration is now letting some employees work from home again.

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults.

Prehabilitation interventions may provide modest reductions in pain, disability, and health care costs, however, certainty of evidence was suboptimal.

The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to study findings.

The Trump administration is attempting to slash NIH funding, terminate research grants, and reduce the agency’s workforce.

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

The US Senate has confirmed the appointment of Mehmet Oz, MD, to head the Centers for Medicare & Medicaid Services.

Galcanezumab for migraine prevention had higher direct costs over 24 months but superior adherence and longer treatment duration compared with standard care.

Advice was presented for clinicians regarding the benefits and harms of cannabis or cannabinoids for the management of chronic noncancer pain.

[O]ur study indicates that inadequate pain control, leading to prolonged pain duration, puts patients at a higher risk of sensory impairments, particularly in vision, smell, and taste functions.